Results 1 to 10 of about 79,996 (276)

Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. [PDF]

Ann Hematol
Bai Z, Hu J, Jin Y, Li X, Sun J, Zhang F, Wu D, Zhao F, Ji P.   +8 more
europepmc   +1 more source

Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study. [PDF]

J Intensive Care, 2023
Saito T, Hayakawa M, Kumano O, Honma Y, Murashita M, Kato J, Fukui S, Takahashi M, Takahashi Y, Tsuchida T, Mizugaki A, Takauji S, Hayamizu M, Yoshida T, Katabami K, Wada T, Maekawa K.   +16 more
europepmc   +1 more source

Survey of clot waveform analysis of normal activated partial thromboplastin time in patients with cirrhosis and sepsis at Le Van Thinh hospital. [PDF]

PLoS One
Phuong Linh TQ, Nhan NT, Thuan LM, Phuong LT.   +3 more
europepmc   +1 more source

A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. [PDF]

Intern Med, 2023
Tsukamoto Y, Sugimoto T, Umeda M, Kato T, Hiura Y, Morita K, Ariyoshi K.   +6 more
europepmc   +1 more source

A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]

Transl Cancer Res
Li HX, Song LH, Chen YH, Zhao J, Zhang XF.   +4 more
europepmc   +1 more source

From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again. [PDF]

Am J Clin Pathol, 2022
May JE, Siniard RC, Taylor LJ, Marques MB, Gangaraju R.   +4 more
europepmc   +1 more source

The preoperative coagulation pattern in liver transplant patients [PDF]

, 1986
Bontempo, FA, Lewis, JH, Ragni, MV, Starzl, TE   +3 more
core  

Impact of Heparin Hemodialysis Catheter Lock on Partial Thromboplastin Time Assays in Inpatients on Therapeutic Intravenous Heparin. [PDF]

Semin Dial
Tuggle TS, Noureddine L, Hobbs RA.
europepmc   +1 more source

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. [PDF]

Genes (Basel), 2022
Zhang F, Mu G, Liu Z, Xie Q, Zhang H, Zhou S, Wang Z, Hu K, Wang Z, Zhao X, Cui Y, Xiang Q.   +11 more
europepmc   +1 more source

Deep learning model for screening causes of activated partial thromboplastin time prolongation using clot waveform analysis at multiple wavelengths. [PDF]

Sci Rep
Matsuda M, Shimomura D, Suzuki T, Tabuchi Y, Kurono H, Nishi K, Arai N, Hoshiyama Y, Kamioka M, Moriyama M, Matsumoto T.   +10 more
europepmc   +1 more source